Longbow Research Reaffirms “Buy” Rating for Sherwin-Williams Company (The) (SHW)

Sherwin-Williams Company (The) (NYSE:SHW)‘s stock had its “buy” rating restated by equities research analysts at Longbow Research in a report released on Monday, October 9th. They presently have a $440.00 target price on the specialty chemicals company’s stock, up from their prior target price of $400.00. Longbow Research’s price objective would indicate a potential upside of 12.91% from the company’s previous close.

A number of other equities analysts have also weighed in on the company. Northcoast Research reiterated a “buy” rating and set a $435.00 price objective (up previously from $375.00) on shares of Sherwin-Williams Company (The) in a research note on Friday, October 6th. Bank of America Corporation upgraded Sherwin-Williams Company (The) from an “underperform” rating to a “buy” rating and raised their target price for the company from $325.00 to $435.00 in a research report on Thursday, October 5th. Vertical Research restated a “hold” rating and set a $375.00 target price (up from $335.00) on shares of Sherwin-Williams Company (The) in a research report on Wednesday, October 4th. Morgan Stanley set a $425.00 target price on Sherwin-Williams Company (The) and gave the company an “overweight” rating in a research report on Wednesday, October 4th. Finally, Credit Suisse Group restated an “outperform” rating and set a $410.00 target price (up from $375.00) on shares of Sherwin-Williams Company (The) in a research report on Wednesday, October 4th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company’s stock. Sherwin-Williams Company (The) currently has an average rating of “Buy” and a consensus price target of $392.49.

Shares of Sherwin-Williams Company (NYSE SHW) opened at 389.70 on Monday. Sherwin-Williams Company has a 12-month low of $239.48 and a 12-month high of $390.60. The company has a market capitalization of $36.18 billion, a PE ratio of 32.13 and a beta of 1.22. The stock’s 50 day moving average price is $361.75 and its 200 day moving average price is $344.37.

Sherwin-Williams Company (The) (NYSE:SHW) last released its quarterly earnings data on Thursday, July 20th. The specialty chemicals company reported $4.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $4.54 by ($0.02). The company had revenue of $3.74 billion for the quarter, compared to analysts’ expectations of $3.83 billion. Sherwin-Williams Company (The) had a net margin of 9.14% and a return on equity of 63.81%. The business’s quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.06 EPS. On average, equities research analysts forecast that Sherwin-Williams Company will post $14.73 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Longbow Research Reaffirms “Buy” Rating for Sherwin-Williams Company (The) (SHW)” was originally posted by BBNS and is the property of of BBNS. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://baseballnewssource.com/markets/sherwin-williams-company-the-shw-given-buy-rating-at-longbow-research/1704410.html.

Hedge funds have recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC purchased a new stake in shares of Sherwin-Williams Company (The) during the 2nd quarter valued at approximately $100,000. American Beacon Advisors Inc. purchased a new stake in shares of Sherwin-Williams Company (The) during the 1st quarter valued at approximately $106,000. Peddock Capital Advisors LLC purchased a new stake in shares of Sherwin-Williams Company (The) during the 2nd quarter valued at approximately $123,000. Parallel Advisors LLC raised its position in shares of Sherwin-Williams Company (The) by 2.6% during the 1st quarter. Parallel Advisors LLC now owns 432 shares of the specialty chemicals company’s stock valued at $144,000 after buying an additional 11 shares during the period. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its position in shares of Sherwin-Williams Company (The) by 7.3% during the 2nd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 429 shares of the specialty chemicals company’s stock valued at $145,000 after buying an additional 29 shares during the period. 73.80% of the stock is currently owned by hedge funds and other institutional investors.

Sherwin-Williams Company (The) Company Profile

The Sherwin-Williams Company (Sherwin-Williams) is engaged in the development, manufacture, distribution and sale of paint, coatings and related products. The Company’s segments are Paint Stores Group, Consumer Group, Global Finishes Group, Latin America Coatings Group and Administrative. The Paint Stores Group markets and sells Sherwin-Williams branded architectural paint and coatings, protective and marine products, original equipment manufacturer (OEM) product finishes and related items.

Analyst Recommendations for Sherwin-Williams Company (The) (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams Company (The) and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.